New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Breast cancer patients with government insurance at higher risk of death

Breast cancer patients with government insurance at higher risk of death

by ECOG-ACRIN Cancer Research GroupSamilia Obeng-Gyasi, MD (The Ohio State University) is the lead author on an analysis of the insurance status of 9800 breast cancer patients and their clinical outco
Oncology December 22,2023
Breast cancer patients with government insurance at higher risk of death

Breast cancer patients with government insurance at higher risk of death

by ECOG-ACRIN Cancer Research GroupSamilia Obeng-Gyasi, MD (The Ohio State University) is the lead author on an analysis of the insurance status of 9800 breast cancer patients and their clinical outco
Oncology December 22,2023
Liver cancer: How liver cells go astray

Liver cancer: How liver cells go astray

byUniversity of BaselOne of the main causes of liver cancer is excessive alcohol consumption. Credit: Biozentrum, University of BaselThe causes of liver cancer are manifold. In addition to metab
Oncology December 22,2023
Liver cancer: How liver cells go astray

Liver cancer: How liver cells go astray

byUniversity of BaselOne of the main causes of liver cancer is excessive alcohol consumption. Credit: Biozentrum, University of BaselThe causes of liver cancer are manifold. In addition to metab
Oncology December 22,2023
Colorectal cancer initiation and progression: the role of low oxygen

Colorectal cancer initiation and progression: the role of low oxygen

byUniversity of LuxembourgScientists from the University of Luxembourg together with researchers from the Integrated Biobank of Luxembourg (IBBL) and the Luxembourg Institute of Health (LIH) hav
Oncology December 22,2023
Colorectal cancer initiation and progression: the role of low oxygen

Colorectal cancer initiation and progression: the role of low oxygen

byUniversity of LuxembourgScientists from the University of Luxembourg together with researchers from the Integrated Biobank of Luxembourg (IBBL) and the Luxembourg Institute of Health (LIH) hav
Oncology December 22,2023
Switch to plant-based diet could boost prostate cancer survival

Switch to plant-based diet could boost prostate cancer survival

by Steven ReinbergFollowing a healthy plant-based diet after a diagnosis of prostate cancer may help prevent the disease from progressing or recurring, a new study suggests.Men who ate adiet&nbs
Oncology December 22,2023
Switch to plant-based diet could boost prostate cancer survival

Switch to plant-based diet could boost prostate cancer survival

by Steven ReinbergFollowing a healthy plant-based diet after a diagnosis of prostate cancer may help prevent the disease from progressing or recurring, a new study suggests.Men who ate adiet&nbs
Oncology December 22,2023
Acute leukemia patients treated with common therapy have increased risk for heart failure

Acute leukemia patients treated with common therapy have increased risk for heart failure

byPerelman School of Medicine at the University of PennsylvaniaPatients with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) who are treated with anthracyclines are at a heigh
Oncology December 22,2023
Acute leukemia patients treated with common therapy have increased risk for heart failure

Acute leukemia patients treated with common therapy have increased risk for heart failure

byPerelman School of Medicine at the University of PennsylvaniaPatients with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) who are treated with anthracyclines are at a heigh
Oncology December 22,2023
Improving emotional well-being, quality of sleep, and decision making in patients at risk for breast cancer

Improving emotional well-being, quality of sleep, and decision making in patients at risk for breast cancer

byTel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study conducted at Tel Aviv University has determined that use of the Inquiry Based Stress Reduction (IBSR) technique among women with
Oncology December 22,2023
Improving emotional well-being, quality of sleep, and decision making in patients at risk for breast cancer

Improving emotional well-being, quality of sleep, and decision making in patients at risk for breast cancer

byTel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study conducted at Tel Aviv University has determined that use of the Inquiry Based Stress Reduction (IBSR) technique among women with
Oncology December 22,2023
Improving treatment for hairy cell leukemia

Improving treatment for hairy cell leukemia

by Melissa Rohman,Northwestern UniversityCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent respon
Oncology December 22,2023
Improving treatment for hairy cell leukemia

Improving treatment for hairy cell leukemia

by Melissa Rohman,Northwestern UniversityCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent respon
Oncology December 22,2023
Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

byAmerican Association for Cancer ResearchNeoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response rates similar to m
Oncology December 22,2023
Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

byAmerican Association for Cancer ResearchNeoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response rates similar to m
Oncology December 22,2023
Improving drug therapy for relapsed leukemia

Improving drug therapy for relapsed leukemia

by Haleigh Ehmsen,Northwestern UniversityResponse rates in all FLT3mutpatients treated at any dose (n = 56) and in those who did (n = 35) or did not (n = 21) receive prior treatment with a
Oncology December 22,2023
Improving drug therapy for relapsed leukemia

Improving drug therapy for relapsed leukemia

by Haleigh Ehmsen,Northwestern UniversityResponse rates in all FLT3mutpatients treated at any dose (n = 56) and in those who did (n = 35) or did not (n = 21) receive prior treatment with a
Oncology December 22,2023
Breast-conserving treatment without surgery not supported at this time

Breast-conserving treatment without surgery not supported at this time

by NRG OncologyResults from NRG Oncology's BR005 study show that breast-conserving treatment without surgery cannot be recommended, based on the study criteria of clinical complete response, radio
Oncology December 22,2023
Breast-conserving treatment without surgery not supported at this time

Breast-conserving treatment without surgery not supported at this time

by NRG OncologyResults from NRG Oncology's BR005 study show that breast-conserving treatment without surgery cannot be recommended, based on the study criteria of clinical complete response, radio
Oncology December 22,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com